NCT06250907

Brief Summary

To evaluate and compare the accuracy of implant placement using dynamic navigation technique versus static template technique in patients with bone tissue flap reconstruction of mandibular defects, thus further guiding the clinical application of dynamic navigation systems to assist in conventional implant placement in patients with mandibular defects.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 9, 2024

Completed
20 days until next milestone

Study Start

First participant enrolled

February 29, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

February 9, 2024

Status Verified

November 1, 2023

Enrollment Period

10 months

First QC Date

February 1, 2024

Last Update Submit

February 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Three-dimensional implant placement accuracy of apical point

    The postoperative cone beam computed tomography (CBCT) was aligned to the preoperative plan in specific software, and the three-dimensional coordinates of the preoperatively planned and actual postoperative implant placement positions were measured separately, from which the three-dimensional distance (in mm) between the apical point of the actual implant and the apical point of the virtual implant was calculated.

    Postoperative day 2±1

Secondary Outcomes (5)

  • Three-dimensional implant placement accuracy of coronal point

    Postoperative day 2±1

  • Three-dimensional implant placement angular accuracy

    Postoperative day 2±1

  • Operation time

    Intraoperative

  • Patient subjective satisfaction

    Postoperative day 14±1

  • Failure rate during implant healing period

    Postoperative day 90±7

Study Arms (2)

Dynamic navigation

EXPERIMENTAL
Procedure: The guidance of dynamic navigation

Static template

ACTIVE COMPARATOR
Procedure: The guidance of static template

Interventions

Osteotomy and implant placement with the guidance of dynamic navigation

Dynamic navigation

Osteotomy and implant placement with the guidance of static template

Static template

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patients between the ages of 18 and 70 (inclusive)
  • Mandibular defects (including Class I defects, limited to the body of the mandible; Class II defects, muscular-mandibular region defects and Class III defects, chin protrusion-muscular-mandibular region defects), which have been reconstructed by mandibular vascularization of free iliac bone, and fibular composite muscular flap grafts for greater than 3 months
  • Normal mouth opening (≥ 40 mm)
  • Trialists voluntarily signed an informed consent form before performing any research-related experimental steps.

You may not qualify if:

  • Presence of localized inflammation in adjacent teeth, including uncontrolled periodontitis (periodontal probing to a depth of \>4 mm)
  • Presence of untreated acute and chronic apical periodontitis in adjacent teeth
  • Oral mucosal lesions (e.g., lichen planus)
  • Adjacent teeth with space-occupying lesions (including cysts, tumors, etc.)
  • Systemic diseases affecting bone healing, wound healing and dental implant treatment (e.g., uncontrolled diabetes mellitus, fasting blood glucose ≥ 8.8 mmol/L despite medication)
  • Uncontrolled and unstabilized severe hypertension
  • Contraindications to routine implant surgery and oral surgery
  • Heart disease (Class II or above)
  • Patients with liver or kidney insufficiency or abnormality
  • Obese patients with body mass index (BMI) \> 28 kg/m2
  • Patients with a history of full-dose radiotherapy, localized radiotherapy to the head or neck
  • Patients requiring long-term high-dose steroid therapy
  • Patients who are receiving or have received in the last 3 months medications (e.g., bisphosphonates) that may affect or promote bone metabolism
  • Consecutive antibiotic therapy or chronic anti-inflammatory therapy (≥3 times per week) within the first 4 weeks of starting the procedure
  • Alcohol or chronic substance abuse
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Micrognathism

Condition Hierarchy (Ancestors)

Jaw AbnormalitiesJaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2024

First Posted

February 9, 2024

Study Start

February 29, 2024

Primary Completion

December 31, 2024

Study Completion

July 31, 2025

Last Updated

February 9, 2024

Record last verified: 2023-11